These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26887826)

  • 21. Correspondence.
    Primavera V; Querques G
    Retina; 2014 Dec; 34(12):e39-40. PubMed ID: 25407235
    [No Abstract]   [Full Text] [Related]  

  • 22. Early evolution of the vitreomacular interface and clinical efficacy after ocriplasmin injection for symptomatic vitreomacular adhesion.
    Meyer JC; Shah GK; Blinder KJ; Waheed NK; Reichel E; Stalmans P; Singer M; Tewari A
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):209-16. PubMed ID: 25707046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reply: To PMID 23881226.
    Stalmans P; Duker JS
    Retina; 2015 Apr; 35(4):e28-9. PubMed ID: 25807179
    [No Abstract]   [Full Text] [Related]  

  • 24. [Research update of ocriplasmin for symptomatic vitreomacular adhesion].
    Zhang M; Chen Y
    Zhonghua Yan Ke Za Zhi; 2014 Nov; 50(11):866-70. PubMed ID: 25582211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?
    Johnson MW
    Am J Ophthalmol; 2013 Feb; 155(2):203-205.e1. PubMed ID: 23312439
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials.
    Haller JA; Stalmans P; Benz MS; Gandorfer A; Pakola SJ; Girach A; Kampik A; Jaffe GJ; Toth CA;
    Ophthalmology; 2015 Jan; 122(1):117-22. PubMed ID: 25240630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.
    Tadayoni R; Holz FG; Zech C; Liu X; Spera C; Stalmans P
    Retina; 2019 Dec; 39(12):2341-2352. PubMed ID: 30308558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction.
    Rossi S; Testa F; Melillo P; Orrico A; Della Corte M; Simonelli F
    BMC Ophthalmol; 2016 Jul; 16():110. PubMed ID: 27430356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Serous Macular Detachments and Visual Disturbance Complicating Consecutive Cases of Symptomatic Vitreomacular Adhesion With Macular Hole Treated With Ocriplasmin.
    Luttrull JK
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):976-8. PubMed ID: 26469240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of vitreomacular interface disease in patients presenting to a tertiary care institution.
    Xu LT; Punjabi OS; Shao J; Ehlers JP; Srivastava SK; Singh RP; Kaiser PK
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):517-20. PubMed ID: 25423630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of vitreomacular traction with intravitreal ocriplasmin preceded by anterior chamber paracentesis: case reports.
    Rizzo S; Bacherini D; Abbruzzese G; Giuntoli M; Virgili G
    Eur J Ophthalmol; 2016 Aug; 26(5):e134-7. PubMed ID: 26951534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.
    Singh RP; Li A; Bedi R; Srivastava S; Sears JE; Ehlers JP; Schachat AP; Kaiser PK
    Br J Ophthalmol; 2014 Mar; 98(3):356-60. PubMed ID: 24357495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole.
    Gandorfer A; Benz MS; Haller JA; Stalmans P; Pakola SJ; Girach A; Kampik A; Toth CA; Jaffe GJ;
    Retina; 2015 Jun; 35(6):1151-7. PubMed ID: 25741816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of intravitreal ocriplasmin for vitreomacular traction and macular hole: a prospective spectral-domain optical coherence tomography study.
    Chatziralli IP; Theodossiadis GP; Parikakis E; Datseris I; Theodossiadis P
    Cutan Ocul Toxicol; 2016 Dec; 35(4):263-9. PubMed ID: 26555379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCRIPLASMIN FOR VITREOMACULAR TRACTION: LOOKING OUTSIDE THE MACULA: A Wide-Field Optical Coherence Tomography Study.
    Cereda MG; Preziosa C; DʼAgostino I; Cozzi M; Bottoni F; Pellegrini M; Giani A; Staurenghi G
    Retina; 2018 Aug; 38(8):1541-1548. PubMed ID: 28767551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral vitreomacular traction resolved with a single intravitreal ocriplasmin injection.
    Katz RS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(3):239-42. PubMed ID: 24708167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMY.
    Scholz P; Sitnilska V; Hess J; Becker M; Michels S; Fauser S
    Retina; 2019 Jan; 39(1):180-185. PubMed ID: 29135889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural course of vitreomacular traction syndrome observed by spectral-domain optical coherence tomography.
    Zhang Z; Dong F; Zhao C; Dai R; Yu W; Zheng L; He F; Yang Z
    Can J Ophthalmol; 2015 Apr; 50(2):172-9. PubMed ID: 25863860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.
    Paul C; Heun C; Müller HH; Hoerauf H; Feltgen N; Wachtlin J; Kaymak H; Mennel S; Koss MJ; Fauser S; Maier MM; Schumann RG; Mueller S; Chang P; Schmitz-Valckenberg S; Kazerounian S; Szurman P; Lommatzsch A; Bertelmann T
    Br J Ophthalmol; 2018 Aug; 102(8):1092-1097. PubMed ID: 29089354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Course of Vitreomacular Traction Managed Initially by Observation.
    Tzu JH; John VJ; Flynn HW; Smiddy WE; Jackson JR; Isernhagen BA; Carver A; Leonard R; Tabandeh H; Boyer DS; Berrocal MH; Suzuki M; Freund KB; Gross JG
    Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):571-6. PubMed ID: 26057761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.